Putting a halt on PRC2 in pediatric glioblastoma
- PMID: 23715325
- DOI: 10.1038/ng.2647
Putting a halt on PRC2 in pediatric glioblastoma
Abstract
Two new studies show that the known histone H3 alteration p.Lys27Met in pediatric glioma leads to globally diminished trimethylation at histone H3 lysine 27. The mutant histone H3 acts as a selective inhibitor of the PRC2 chromatin-modifying complex by binding and presumably sequestering it, shedding light on how this variant may contribute to the etiology of these highly malignant brain tumors.
Comment on
-
Recurring mutations found by sequencing an acute myeloid leukemia genome.N Engl J Med. 2009 Sep 10;361(11):1058-66. doi: 10.1056/NEJMoa0903840. Epub 2009 Aug 5. N Engl J Med. 2009. PMID: 19657110 Free PMC article.
-
Gene mutation and AML pathogenesis.Blood. 2011 Nov 17;118(20):5366-7. doi: 10.1182/blood-2011-09-379081. Blood. 2011. PMID: 22096254
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical